Navigation Links
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference in New York on April 2, 2009
Date:3/26/2009

SAN DIEGO, March 26 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present the company's corporate overview on Thursday, April 2, 2009 at 9:00am Eastern Time (6:00am Pacific Time) during the BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference at the Millennium Broadway Hotel in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 90 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company is currently developing Acetavance(TM) (intravenous acetaminophen), its product candidate for the treatment of acute pain and fever. For more information about Cadence's pipeline, visit www.cadencepharm.com.

Cadence(TM) and Acetavance(TM) are trademarks of Cadence Pharmaceuticals, Inc.

    Contacts:  William R. LaRue
               SVP, CFO
               Cadence Pharmaceuticals, Inc.
               858-436-1400


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
2. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
3. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIO Investor Forum
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIOCOM Investor Conference 2007
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2007 Financial Results
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
8. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
9. Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
10. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008
11. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014 Human Longevity, ... therapeutic company focused on extending the healthy, high performance ... Franz Och , Ph.D., an expert in machine learning ... Och comes to HLI from Google where he was ... He will report directly to HLI Co-Founder and CEO, ...
(Date:7/29/2014)... (July 29, 2014) Tough, ultralight foam of ... shape through a chemical process invented at Rice University. ... looks like a nanoscale building, with floors and walls ... pair of two-dimensional materials: floors and walls of graphene ... nitride platelets. , The researchers say the foam ...
(Date:7/29/2014)... , July 29, 2014  The Society ... new and updated program for the 9 th ... 12, 2014 in Amelia Island , Florida.  ... and investigators remains unchanged, however, the topics and ... and networking opportunity among all stakeholders with a ...
(Date:7/29/2014)... Second generation biofuels are a viable solution to the dilemma ... gas is very cheap, this is affecting the biofuels market ... they could be in comparison to natural gas. This, ... difficult for renewable energy developers to get the economics to ... reasons, certain companies have shifted their focused within renewable energy. ...
Breaking Biology Technology:Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist 2Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist 3Tough foam from tiny sheets 2TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 2TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 3Renewable Waste Intelligence: Could Renewable Chemicals Be the Future for the Renewable Energy Industry? 2
... NORWOOD, Mass., Aug. 24 Advanced Instruments has introduced a ... experience when purchasing osmometers, cryoscopes, and microbiological laboratory instruments. The ... es.com , was developed from the perspective of ... application information, scientific materials, and technical support. , , ...
... SAN DIEGO, Aug. 24 Orexigen((R)) Therapeutics, Inc. (Nasdaq: ... joined the Company as Chief Commercial Officer. Mr. Booth ... to Orexigen. Most recently he served as President of ... commercial, medical and scientific affairs, business development and all support ...
... August 24 Foamix Ltd., a leading,developer of topical ... been awarded US Patent #7575739 pertaining to its foam,technology. ... of heat and chemical burns, wounds, bacterial, fungal and ... the Company,s CEO stated, "The novelty of our foam,technology ...
Cached Biology Technology:Advanced Instruments Introduces Next-Generation Web Site 2Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer 2Foamix Receives US Patent on Novel Foam Technology 2
(Date:7/29/2014)... have been plaguing the Northern Territories in Canada and ... in the U.S. continue on. NASA,s Aqua satellite ... Spectroradiometer, MODIS, instrument on July 26, 2014. Actively burning ... red. Copious amount of smoke are drifting northward in ... residents of Yellowknife. Fire has caused power outages ...
(Date:7/29/2014)... easier method to create DNAprotein conjugates. The method ... diseases. , DNA linked to proteins including ... be used in diagnostic techniques, nanotechnology and other ... DNA can be used for purposes such ... material. The method also provides easier access to ...
(Date:7/29/2014)... from scientists at the University of Kent has shown ... are regulated a breakthrough that could have a ... from Kent,s School of Biosciences uncovered the mechanism whereby ... known as actin filaments are ,fine-tuned, to ... filaments appear to completely stable, providing a framework for ...
Breaking Biology News(10 mins):New method provides researchers with efficient tool for tagging proteins 2
... This press release is available in French . ... people are not slower but rather wiser than young brains, ... performance, according research undertaken at the University Geriatrics Institute of ... the Univeristy of Montreal. "The older brain has experience and ...
... Society of Interventional Radiology Foundation,s Discovery Campaign, which ... medicine into new areas of discovery, announced a ... manufacturer of medical devices, pharmaceuticals and medical supplies, ... is a "Visionary" level supporter. "Collaboration ...
... one way that old-fashioned newsprint beats the Internet. Tulane ... "TU-103," that can use paper to produce butanol, a ... They are currently experimenting with old editions of the ... success., ,TU-103 is the first bacterial strain from nature ...
Cached Biology News:Clinical study shows young brains lack the wisdom of their elders 2Cars could run on recycled newspaper, Tulane scientists say 2
...
... Fully adjustable mixing angle, Variable speed, Digital ... a number of different sized tubes, Spillage ... cultures, keeping biological samples in suspension and ... be used in incubators up to 60C ...
... The DNA Engine Opticon 2 real-time PCR ... LEDs for fluorescence excitation (470-505 nm) and ... nm, 540-700 nm). The Opticon 2 system ... cycler, which includes a thermal gradient feature. ...
... Multicolor capability allows detection of SYBR ... channel, and a range of fluorophores in ... VIC, and TAMRA for a multitude ... discrimination. DNA Engine thermal cycler offers precision ...
Biology Products: